Diffusion tensor imaging correlates of depressive symptoms in Parkinson disease.


Journal

The Journal of comparative neurology
ISSN: 1096-9861
Titre abrégé: J Comp Neurol
Pays: United States
ID NLM: 0406041

Informations de publication

Date de publication:
07 2022
Historique:
revised: 30 01 2022
received: 20 12 2021
accepted: 03 02 2022
pubmed: 14 2 2022
medline: 24 5 2022
entrez: 13 2 2022
Statut: ppublish

Résumé

Depression is a heterogeneous clinical syndrome prevalent in patients with Parkinson disease (PD) that remains incompletely understood. Further, the differences in biomarkers of depression in PD and in non-PD patients are unclear. The subcallosal cingulate cortex (SCC) and its connections have been implicated in the pathophysiology of major depressive disorder (MDD). Diffusion tensor imaging (DTI) provides a tool to quantify MDD-related structural abnormalities underlying depressive symptoms in PD. Diffusion-weighted magnetic resonance imaging data were collected from 31 patients with PD. Depression symptom severity was measured using the Beck Depression Inventory (BDI-II), and assessed using three subscales: dysphoric mood, loss of interest/pleasure, and somatic symptoms. Probabilistic tractography methods were used to quantify the SCC connectivity to target regions in cortico-limbic-striatal network (ventral striatum, medial prefrontal cortex [mPFC], dorsal anterior cingulate cortex, and uncinate fasciculus), while fractional anisotropy (FA) was calculated in predefined white matter regions of interest. DTI data were correlated with severity of depression across three domains. SCC-mPFC connectivity in the left hemisphere was positively correlated with severity of dysphoric mood (Benjamini-Hochberg adjusted p = .02). Region of interest-based analyses demonstrated a significant and distinct topographic association between FA and dysphoric mood, loss of interest/pleasure, and somatic symptom severity, although these findings did not maintain significance after applying the false discovery rate correction. Abnormal SCC connectivity underlies depressive symptoms in both PD and MDD, suggesting that interventions used for MDD should be explored in treating depressive symptoms in PD, particularly depression dominated by dysphoric mood.

Identifiants

pubmed: 35152429
doi: 10.1002/cne.25310
pmc: PMC9119905
mid: NIHMS1778455
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1729-1738

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS097782
Pays : United States

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Psychiatry Res Neuroimaging. 2017 Mar 30;261:72-74
pubmed: 28142056
Hum Brain Mapp. 2014 Apr;35(4):1325-33
pubmed: 23417856
J Neurol Sci. 2014 Nov 15;346(1-2):145-8
pubmed: 25194633
Mov Disord. 2006 Aug;21(8):1169-74
pubmed: 16685687
J Neurol Neurosurg Psychiatry. 2014 Jun;85(6):675-83
pubmed: 24227759
J Psychiatry Neurosci. 2017 May;42(3):150-163
pubmed: 27780031
Neurobiol Aging. 2019 Aug;80:203-209
pubmed: 31207552
Mol Psychiatry. 2020 Jul;25(7):1511-1525
pubmed: 31471575
Magn Reson Med. 2003 Nov;50(5):1077-88
pubmed: 14587019
Neuroimage. 2004;23 Suppl 1:S208-19
pubmed: 15501092
Nat Med. 2017 Jan;23(1):28-38
pubmed: 27918562
Curr Neurol Neurosci Rep. 2013 Dec;13(12):409
pubmed: 24190780
Brain Stimul. 2013 Sep;6(5):737-9
pubmed: 23602025
Behav Brain Res. 2009 Aug 12;201(2):239-43
pubmed: 19428640
Neuroimage. 2008 Apr 1;40(2):570-582
pubmed: 18255316
J Neurol. 2007 Sep;254(9):1170-3
pubmed: 17710361
Neuroimage. 2013 Jun;73:239-54
pubmed: 22846632
Int J Neuropsychopharmacol. 2008 Mar;11(2):173-83
pubmed: 17708780
Biol Psychiatry. 2013 Dec 15;74(12):898-907
pubmed: 23910949
Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Jan;6(1):10-19
pubmed: 32741703
Am J Psychiatry. 2017 Jun 1;174(6):533-545
pubmed: 28335622
CNS Spectr. 2008 Aug;13(8):663-81
pubmed: 18704022
Parkinsonism Relat Disord. 2012 Aug;18(7):809-13
pubmed: 22652466
Neuroimage. 2006 Jul 15;31(4):1487-505
pubmed: 16624579
Neuroimage. 2007 Jan 1;34(1):144-55
pubmed: 17070705
Neuroimage Clin. 2017 Jul 15;16:98-110
pubmed: 28765809
PLoS One. 2010 Nov 29;5(11):e13945
pubmed: 21124764
J Int Neuropsychol Soc. 2011 Nov;17(6):1058-66
pubmed: 22040900
AJNR Am J Neuroradiol. 2010 Nov;31(10):1861-6
pubmed: 20705702
J Neurosci. 2008 Nov 19;28(47):12341-8
pubmed: 19020027

Auteurs

Lauren Uhr (L)

Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

Evangelia Tsolaki (E)

Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

Nader Pouratian (N)

Department of Neurological Surgery, UT Southwestern Medical Center, Dallas, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH